Vietnam Hyperglycemics Research
6 comprehensive market analysis studies and research reports on the Vietnam Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 75 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Insulin Market
CAGR: 3.87%
Study Period : 2019 - 2030
Middle East And Africa Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
SGLT2 Market
CAGR: 8.68%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
Healthcare
Categories
6 Healthcare Reports
Categories
Showing 6 of 6 results in Hyperglycemics
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 8.35%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
TRENDING REPORTS
Insulin Market
CAGR: 3.87%
Study Period : 2019 - 2030
Middle East And Africa Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
SGLT2 Market
CAGR: 8.68%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Asia - Pacific Human Insulin Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Vietnam
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
